Survodutide (BI 456906) is an experimental

peptide Peptides are short chains of amino acids linked by peptide bonds. A polypeptide is a longer, continuous, unbranched peptide chain. Polypeptides that have a molecular mass of 10,000 Da or more are called proteins. Chains of fewer than twenty am ...

that works as a dual

glucagon Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It raises the concentration of glucose and fatty acids in the bloodstream and is considered to be the main catabolic hormone of the body. It is also used as a Glucagon (medic ...

/ GLP-1 receptor agonist. Unlike other dual GLP-1/glucagon dual agonists, it is a

analog rather than an analog of oxyntomodulin. It is developed by

Boehringer Ingelheim C.H. Boehringer Sohn AG & Co. is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's List of la ...

as a weight loss drug.

References

{{reflist Peptide therapeutics Glucagon receptor agonists GLP-1 receptor agonists Drugs developed by Boehringer Ingelheim Experimental anti-obesity drugs